Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Ishibashi · SciRah

Researcher profile · Semantic Scholar

S. Ishibashi

Share profile

S. Ishibashi — researcher profile on SciRah

h-index: 76
Works: 358
Citations: 23K

Most-cited papers

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
M. Kinoshita, K. Yokote, H. Arai, M. Iida +28 more
2018Journal of atherosclerosis and thrombosis617 citations Open access
Semantic Scholar
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
A. Pradhan, N. Paynter, B. Everett, R. Glynn +10 more
2018American Heart Journal280 citations Open access
Semantic Scholar
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
K. Ueki, Takayoshi Sasako, Yukiko Okazaki, Masayuki Kato +151 more
2017The Lancet Diabetes and Endocrinology252 citations Open access
Semantic Scholar
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
M. Harada-Shiba, H. Arai, Y. Ishigaki, S. Ishibashi +8 more
2018Journal of atherosclerosis and thrombosis185 citations Open access
Semantic Scholar
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial.
S. Ishibashi, S. Yamashita, H. Arai, E. Araki +4 more
2016Atherosclerosis181 citations Open access
Semantic Scholar
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
E. Araki, S. Yamashita, H. Arai, K. Yokote +9 more
2018Diabetes Care148 citations
Semantic Scholar
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial.
S. Ishibashi, H. Arai, K. Yokote, E. Araki +2 more
2017Journal of Clinical Lipidology138 citations Open access
Semantic Scholar
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
H. Arai, S. Yamashita, K. Yokote, E. Araki +2 more
2018Journal of atherosclerosis and thrombosis116 citations Open access
Semantic Scholar
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
J. Fruchart, Raul D. Santos, C. Aguilar-Salinas, M. Aikawa +51 more
2019Cardiovascular Diabetology114 citations Open access
Semantic Scholar
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia.
H. Arai, S. Yamashita, K. Yokote, E. Araki +2 more
2017Atherosclerosis111 citations Open access
Semantic Scholar
Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
Yoshinori Osaki, Y. Nakagawa, S. Miyahara, H. Iwasaki +12 more
2015Biochemical and Biophysical Research Communications - BBRC78 citations
Semantic Scholar
Guidance for the diagnosis and treatment of hypolipidemia disorders.
Cindy Bredefeld, M. Hussain, M. Averna, D. Black +21 more
2022Journal of Clinical Lipidology63 citations Open access
Semantic Scholar
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
K. Yokote, S. Yamashita, H. Arai, E. Araki +2 more
2019International Journal of Molecular Sciences57 citations Open access
Semantic Scholar
The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin
Tomoyuki Kurashina, K. Dezaki, Masashi Yoshida, Rauza Sukma Rita +7 more
2015Scientific Reports56 citations Open access
Semantic Scholar
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study
H. Itoh, I. Komuro, M. Takeuchi, T. Akasaka +38 more
2018Diabetes Care55 citations Open access
Semantic Scholar
Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia.
S. Yamashita, H. Arai, K. Yokote, E. Araki +2 more
2018Journal of Clinical Lipidology44 citations Open access
Semantic Scholar
Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance
I. Matsuba, Ren Matsuba, S. Ishibashi, S. Yamashita +4 more
2018Journal of Diabetes Investigation42 citations Open access
Semantic Scholar
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study
E. Araki, S. Yamashita, H. Arai, K. Yokote +9 more
2019Diabetes, obesity and metabolism41 citations Open access
Semantic Scholar
Current Diagnosis and Management of Abetalipoproteinemia
Manabu Takahashi, H. Okazaki, Ken Ohashi, M. Ogura +7 more
2021Journal of atherosclerosis and thrombosis40 citations Open access
Semantic Scholar
Peripheral circadian rhythms in the liver and white adipose tissue of mice are attenuated by constant light and restored by time-restricted feeding
Daisuke Yamamuro, Manabu Takahashi, Shuichi Nagashima, Tetsuji Wakabayashi +8 more
2020PLoS ONE39 citations Open access
Semantic Scholar
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination
S. Yamashita, H. Arai, K. Yokote, E. Araki +4 more
2019International Journal of Molecular Sciences37 citations Open access
Semantic Scholar
Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
Hirotoshi Ohmura, Yoshifumi Fukushima, A. Mizuno, K. Niwa +5 more
2017International Heart Journal37 citations Open access
Semantic Scholar
Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials
K. Yokote, S. Yamashita, H. Arai, E. Araki +4 more
2021Cardiovascular Diabetology36 citations Open access
Semantic Scholar
Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
T. Moriya, Shiro Tanaka, H. Sone, S. Ishibashi +5 more
2017Journal of diabetes and its complications35 citations
Semantic Scholar
Current Diagnosis and Management of Primary Chylomicronemia
H. Okazaki, T. Gotoda, M. Ogura, S. Ishibashi +8 more
2021Journal of atherosclerosis and thrombosis32 citations Open access
Semantic Scholar
β-Cell–Specific Deletion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) Reductase Causes Overt Diabetes due to Reduction of β-Cell Mass and Impaired Insulin Secretion
Ada Admin, Shoko Takei, Shuichi Nagashima, Akihito Takei +14 more
2020Diabetes32 citations Open access
Semantic Scholar
Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study
K. Kario, K. Okada, Mitsunobu Murata, Daisuke Suzuki +9 more
2020The Journal of Clinical Hypertension30 citations Open access
Semantic Scholar
Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages
Kent Sakai, Shuichi Nagashima, Tetsuji Wakabayashi, Bayasgalan Tumenbayar +14 more
2018Arteriosclerosis, Thrombosis and Vascular Biology29 citations Open access
Semantic Scholar
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
S. Yamashita, Daisaku Masuda, M. Harada-Shiba, H. Arai +5 more
2021Journal of atherosclerosis and thrombosis27 citations Open access
Semantic Scholar
Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
K. Okada, K. Kotani, H. Yagyu, A. Ando +2 more
2014Endocrine27 citations Open access
Semantic Scholar
Myeloid HMG-CoA Reductase Determines Adipose Tissue Inflammation, Insulin Resistance, and Hepatic Steatosis in Diet-Induced Obese Mice
Akihito Takei, Shuichi Nagashima, Shoko Takei, Daisuke Yamamuro +8 more
2019Diabetes26 citations Open access
Semantic Scholar
Small Fibre Neuropathy Is Associated With Impaired Vascular Endothelial Function in Patients With Type 2 Diabetes
A. Ando, Michiaki Miyamoto, N. Saito, K. Kotani +3 more
2021Frontiers in Endocrinology24 citations Open access
Semantic Scholar
Lipoprotein Subfractions Highly Associated With Renal Damage in Familial Lecithin: Cholesterol Acyltransferase Deficiency
Masayuki Kuroda, A. Holleboom, E. Stroes, Sakiyo Asada +6 more
2014Arteriosclerosis, Thrombosis and Vascular Biology23 citations
Semantic Scholar
New Pyripyropene A Derivatives, Highly SOAT2-Selective Inhibitors, Improve Hypercholesterolemia and Atherosclerosis in Atherogenic Mouse Models
Taichi Ohshiro, M. Ohtawa, Tohru Nagamitsu, Daisuke Matsuda +5 more
2015Journal of Pharmacology and Experimental Therapeutics21 citations Open access
Semantic Scholar
Cardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes
A. Ando, Michiaki Miyamoto, K. Kotani, K. Okada +2 more
2017Journal of Diabetes Research20 citations Open access
Semantic Scholar
Leptin sensitizing effect of 1,3-butanediol and its potential mechanism
Masayo Isoda, Ken Ebihara, Nagisa Sawayama, Akiko Murakami +9 more
2021Scientific Reports18 citations Open access
Semantic Scholar
Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study
M. Ogura, M. Harada-Shiba, Daisaku Masuda, H. Arai +6 more
2021Journal of atherosclerosis and thrombosis18 citations Open access
Semantic Scholar
Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications Study.
Shiro Tanaka, Sachiko Tanaka, S. Iimuro, S. Ishibashi +9 more
2016Journal of diabetes and its complications18 citations
Semantic Scholar
Esterification of 4β-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT
Daisuke Yamamuro, Hisataka Yamazaki, J. Osuga, K. Okada +9 more
2020Journal of Lipid Research17 citations Open access
Semantic Scholar
Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow
Tetsuji Wakabayashi, Manabu Takahashi, Daisuke Yamamuro, T. Karasawa +7 more
2018Arteriosclerosis, Thrombosis and Vascular Biology17 citations Open access
Semantic Scholar
Possible involvement of PCSK9 overproduction in hyperlipoproteinemia associated with hepatocellular carcinoma: A case report.
Shuichi Nagashima, K. Morishima, H. Okamoto, S. Ishibashi
2016Journal of Clinical Lipidology16 citations
Semantic Scholar
Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
T. Teramoto, J. Sasaki, S. Ishibashi, S. Birou +14 more
2014Journal of atherosclerosis and thrombosis16 citations Open access
Semantic Scholar
Critical role of SREBP-1c large-VLDL pathway in environment-induced hypertriglyceridemia of apoA-V deficiency
Mikio Takanashi, Takeshi Kimura, Chengcheng Li, Masaki Tanaka +17 more
2019Arteriosclerosis, Thrombosis and Vascular Biology15 citations Open access
Semantic Scholar
Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study
K. Okada, S. Hoshide, Mitsutoshi Kato, Hiroshi Kanegae +2 more
2020The Journal of Clinical Hypertension14 citations Open access
Semantic Scholar
Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver[S]
Shuichi Nagashima, H. Yagyu, Ryuichi Tozawa, Fumiko Tazoe +9 more
2015Journal of Lipid Research14 citations Open access
Semantic Scholar
Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome
Shuichi Nagashima, Tetsuji Wakabayashi, N. Saito, Manabu Takahashi +3 more
2020Journal of Diabetes Investigation13 citations Open access
Semantic Scholar
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study
H. Itoh, I. Komuro, M. Takeuchi, T. Akasaka +38 more
2018Diabetes, obesity and metabolism13 citations Open access
Semantic Scholar
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
R. Naito, H. Daida, Daisaku Masuda, M. Harada-Shiba +6 more
2021Journal of atherosclerosis and thrombosis10 citations Open access
Semantic Scholar
Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
S. Yamashita, M. Okazaki, Takeshi Okada, Daisaku Masuda +4 more
2021Journal of atherosclerosis and thrombosis10 citations Open access
Semantic Scholar
A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Indicated Significant Improvement in Glycemic and Liver Function-related Parameters
K. Yokote, S. Yamashita, H. Arai, E. Araki +2 more
2018Atherosclerosis Supplements10 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Yamashita×21
Invite
S. Yamashita — researcher profile on SciRah
K. Yokote×19
Invite
K. Yokote — researcher profile on SciRah
H. Arai×18
Invite
H. Arai — researcher profile on SciRah
E. Araki×14
Invite
E. Araki — researcher profile on SciRah

×12

Invite

H. Suganami — researcher profile on SciRah

Manabu Takahashi×12

Invite

Manabu Takahashi — researcher profile on SciRah

Shuichi Nagashima×10

Invite

Shuichi Nagashima — researcher profile on SciRah

Invite

H. Daida — researcher profile on SciRah

Daisuke Yamamuro×8

Invite

Daisuke Yamamuro — researcher profile on SciRah

Tetsuji Wakabayashi×8

Invite

Tetsuji Wakabayashi — researcher profile on SciRah

Akihito Takei×7

Invite

Akihito Takei — researcher profile on SciRah

Invite

Shoko Takei — researcher profile on SciRah